Expertise in
6
conditions

Javier M. De La Serna

Madrid, MD, ES 
Expertise in
6
conditions
Madrid, MD, ES 

Overview

Javier De La Serna practices practicing medicine in Madrid, Spain.

Mr. De La Serna is highly rated in 6 conditions, according to our data. His clinical expertise encompasses Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Acute Promyelocytic Leukemia, Small Lymphocytic Lymphoma (SLL), and Bone Marrow Transplant.

He is actively involved in clinical research, co-authoring 50 peer reviewed articles and participating in 1 clinical trial.

Gender

Male

Locations

Madrid, MD, Spain
Other Locations
Getafe, MD 28906, Spain
La Paz, MD, Spain
Oviedo, AS, Spain
Murcia, MU, Spain

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Multicenter, Non-randomized, Open Label Study to Evaluate the Efficacy and Security of Ibrutinib Followed by Ibrutinib Consolidation in Combination With Ofatumumab in Previously Untreated Patients With Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL)
A Multicenter, Non-randomized, Open Label Study to Evaluate the Efficacy and Security of Ibrutinib Followed by Ibrutinib Consolidation in Combination With Ofatumumab in Previously Untreated Patients With Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL)
Enrollment Status: Unknown
Publish Date: September 16, 2022
Intervention Type: Drug
Study Drug: Ibrutinib
Study Phase: Phase 2

50 Total Publications

Fixed-Duration versus Continuous Treatment for Chronic Lymphocytic Leukemia.
Fixed-Duration versus Continuous Treatment for Chronic Lymphocytic Leukemia.
Journal: The New England journal of medicine
Published: December 08, 2025

Frequently Asked Questions about Javier M. De La Serna

Is Javier M. De La Serna a top-rated expert for Chronic Lymphocytic Leukemia (CLL)?

MediFind is an objective health platform that identifies experts based on real-world data. Javier M. De La Serna is classified as an Advanced expert for Chronic Lymphocytic Leukemia (CLL), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Javier M. De La Serna participate in research or clinical trials?

Yes. Javier M. De La Serna has published 50 articles and abstracts on conditions like Chronic Lymphocytic Leukemia (CLL). You can view a list of Javier M. De La Serna's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. De La Serna's expertise for a condition
ConditionClose
      View All 9 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile